Trial Profile
An observational study to evaluate the relationship between use of dalfampridine extended release (D-ER) and functional impairment in patients with multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 19 Dec 2015 New trial record